首页> 美国卫生研究院文献>Molecules >Study of the Extraction Process and In Vivo Inhibitory Effect of Ganoderma Triterpenes in Oral Mucosa Cancer
【2h】

Study of the Extraction Process and In Vivo Inhibitory Effect of Ganoderma Triterpenes in Oral Mucosa Cancer

机译:灵芝三萜类化合物在口腔黏膜癌中的提取工艺及体内抑制作用的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the reported study was to optimize the extraction process for ganoderma triterpenes and to investigate the in vivo inhibitory effect of ganoderma triterpenes on the genesis and progression of oral cancer. Single-factor and orthogonal methods were used to investigate the effects of extraction solvent, solvent amount, extraction time, extraction temperature, and number of extractions, on the extraction rate for ganoderma triterpenes. A golden hamster model with cheek pouch dynamic canceration was established to receive oral treatment of ganoderma triterpenes water solution. Animals were continuously monitored, oral tissue samples were collected for histopathologic examination, and changes in the expression of VEGF (vascular endothelial growth factor) and Caspase-3 were detected by immunohistochemical methods. Optimization of the experimental conditions allowed the identification of the optimal extraction conditions: 90% ethanol as the extraction solvent, a solvent amount by the liquid-material ratio of 35 mL/g, extraction time of 2 h and extraction temperature of 80 °C. Under these conditions, the average extraction rate of ganoderma triterpenes was 1.09%. Tests in golden hamsters showed that compared with the model group during the same period, animals in the treatment group had better conditions, constantly larger number of normal cases shown by histopathologic results (P < 0.01), and consistently smaller numbers of cases with paraplasm (P < 0.05). Immunohistochemical results showed that compared with the model group, the treatment group had significantly lower (P < 0.05) rates of positive VEGF expression in the normal state, simple epithelial hyperplasia, epithelial dysplasia or squamous cell carcinoma disease stages. Caspase-3 expression showed a tendency toward a gradual increase with the worsening of disease severity in each group. Compared with the model group, the treatment group had significantly lower (P < 0.05) rates of positive Caspase-3 in the normal state, simple epithelial hyperplasia, epithelial dysplasia or squamous cell carcinoma disease grades. Using the optimized extraction process, ganoderma triterpenes could be extracted with high efficiency, and the results of animal tests showed inhibitory effects of ganoderma triterpenes on oral mucosa cancer.
机译:报道的研究目的是优化灵芝三萜的提取工艺,并研究灵芝三萜对口腔癌的发生和发展的体内抑制作用。采用单因素和正交方法研究了提取溶剂,溶剂量,提取时间,提取温度和提取次数对灵芝三萜类化合物提取率的影响。建立了具有颊囊动态癌变的金黄仓鼠模型,以接受口服灵芝三萜类水溶液的治疗。连续监测动物,收集口腔组织样品以进行组织病理学检查,并通过免疫组织化学方法检测VEGF(血管内皮生长因子)和Caspase-3的表达变化。通过优化实验条件,可以确定最佳的提取条件:90%的乙醇为提取溶剂,液-液比为35 mL / g的溶剂量,提取时间为2 h,提取温度为80°C。在这些条件下,灵芝三萜的平均提取率为1.09%。在金色仓鼠中进行的测试表明,与同期的模型组相比,治疗组的动物病情更好,组织病理学结果显示正常病例数不断增加(P <0.01),并且寄生虫病例数始终较少( P <0.05)。免疫组织化学结果显示,与模型组相比,治疗组在正常状态,单纯上皮增生,上皮异型增生或鳞状细胞癌疾病阶段中的VEGF阳性表达率显着降低(P <0.05)。在每组中,随着疾病严重程度的恶化,Caspase-3表达呈现出逐渐增加的趋势。与模型组相比,治疗组在正常状态,单纯上皮增生,上皮异型增生或鳞状细胞癌疾病分级中,Caspase-3阳性率显着降低(P <0.05)。使用优化的提取工艺,可以高效提取灵芝三萜类化合物,动物实验结果表明,灵芝三萜类化合物对口腔粘膜癌具有抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号